RTI Surgical Holdings Inc (NASDAQ:RTIX) Receives $7.50 Consensus Target Price from Brokerages

RTI Surgical Holdings Inc (NASDAQ:RTIX) has earned a consensus rating of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $7.50.

Several equities research analysts have recently weighed in on RTIX shares. Cantor Fitzgerald started coverage on RTI Surgical in a research note on Wednesday, May 29th. They issued an “overweight” rating and a $7.00 price target for the company. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a research note on Saturday.

Several hedge funds have recently modified their holdings of the company. Paradigm Capital Management Inc. NY increased its stake in shares of RTI Surgical by 1.3% in the second quarter. Paradigm Capital Management Inc. NY now owns 5,988,670 shares of the medical equipment provider’s stock valued at $25,452,000 after buying an additional 74,800 shares during the period. BlackRock Inc. increased its stake in shares of RTI Surgical by 5.4% in the second quarter. BlackRock Inc. now owns 5,352,990 shares of the medical equipment provider’s stock valued at $22,751,000 after buying an additional 271,851 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of RTI Surgical by 2.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,756,346 shares of the medical equipment provider’s stock valued at $17,599,000 after purchasing an additional 93,444 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of RTI Surgical by 2.2% during the 2nd quarter. Vanguard Group Inc. now owns 2,810,840 shares of the medical equipment provider’s stock valued at $11,946,000 after purchasing an additional 59,796 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. boosted its position in shares of RTI Surgical by 2.9% during the 2nd quarter. D. E. Shaw & Co. Inc. now owns 1,045,276 shares of the medical equipment provider’s stock valued at $4,442,000 after purchasing an additional 29,243 shares in the last quarter. 58.08% of the stock is owned by institutional investors.

RTIX traded up $0.09 on Monday, reaching $3.18. The stock had a trading volume of 58,800 shares, compared to its average volume of 190,869. RTI Surgical has a fifty-two week low of $2.95 and a fifty-two week high of $6.15. The firm has a 50-day moving average of $3.90 and a 200-day moving average of $4.68. The company has a current ratio of 3.14, a quick ratio of 1.22 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $228.35 million, a price-to-earnings ratio of 26.50 and a beta of 1.37.

RTI Surgical (NASDAQ:RTIX) last issued its earnings results on Thursday, August 1st. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. RTI Surgical had a positive return on equity of 3.55% and a negative net margin of 1.08%. The business had revenue of $82.31 million during the quarter. Sell-side analysts anticipate that RTI Surgical will post 0.02 EPS for the current fiscal year.

About RTI Surgical

RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Featured Article: Bear Market – How and Why They Occur

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.